Site-directed RNA Editing: Recent Advances and Open Challenges

Overview

Journal RNA Biol

Specialty Molecular Biology

Date 2021 Sep 27

PMID 34569891

Citations 28

Authors

Hamid Mansouri Khosravi

Michael F Jantsch

Affiliations

Soon will be listed here.

Abstract

RNA editing by cytosine and adenosine deaminases changes the identity of the edited bases. While cytosines are converted to uracils, adenines are converted to inosines. If coding regions of mRNAs are affected, the coding potential of the RNA can be changed, depending on the codon affected. The recoding potential of nucleotide deaminases has recently gained attention for their ability to correct genetic mutations by either reverting the mutation itself or by manipulating processing steps such as RNA splicing. In contrast to CRISPR-based DNA-editing approaches, RNA editing events are transient in nature, therefore reducing the risk of long-lasting inadvertent side-effects. Moreover, some RNA-based therapeutics are already FDA approved and their use in targeting multiple cells or organs to restore genetic function has already been shown. In this review, we provide an overview on the current status and technical differences of site-directed RNA-editing approaches. We also discuss advantages and challenges of individual approaches.

Citing Articles

ADAR Therapeutics as a New Tool for Personalized Medicine.

Bertoli M, La Via L, Barbon A Genes (Basel). 2025; 16(1).

PMID: 39858624 PMC: 11764986. DOI: 10.3390/genes16010077.

RNA editing in disease: mechanisms and therapeutic potential.

Tamizkar K, Jantsch M RNA. 2025; 31(3):359-368.

PMID: 39746751 PMC: 11874977. DOI: 10.1261/rna.080331.124.

Nucleoside Analogs in ADAR Guide Strands Enable Editing at 5'-G Sites.

Manjunath A, Cheng J, Campbell K, Jacobsen C, Mendoza H, Bierbaum L Biomolecules. 2024; 14(10).

PMID: 39456162 PMC: 11506087. DOI: 10.3390/biom14101229.

Rapid generation of long, chemically modified pegRNAs for prime editing.

Lei X, Huang A, Chen D, Wang X, Ji R, Wang J Nat Biotechnol. 2024; .

PMID: 39349835 DOI: 10.1038/s41587-024-02394-x.

RBPs: an RNA editor's choice.

Fierro-Monti I Front Mol Biosci. 2024; 11:1454241.

PMID: 39165644 PMC: 11333368. DOI: 10.3389/fmolb.2024.1454241.

References

Nishikura K . Functions and regulation of RNA editing by ADAR deaminases. Annu Rev Biochem. 2010; 79:321-49. PMC: 2953425. DOI: 10.1146/annurev-biochem-060208-105251. View

Hangeland J, Flesher J, Deamond S, Lee Y, Tso P, Frost J . Tissue distribution and metabolism of the [32P]-labeled oligodeoxynucleoside methylphosphonate-neoglycopeptide conjugate, [YEE(ah-GalNAc)3]-SMCC-AET-pUmpT7, in the mouse. Antisense Nucleic Acid Drug Dev. 1997; 7(3):141-9. DOI: 10.1089/oli.1.1997.7.141. View

Reardon S . Step aside CRISPR, RNA editing is taking off. Nature. 2020; 578(7793):24-27. DOI: 10.1038/d41586-020-00272-5. View

Vogel P, Schneider M, Wettengel J, Stafforst T . Improving site-directed RNA editing in vitro and in cell culture by chemical modification of the guideRNA. Angew Chem Int Ed Engl. 2014; 53(24):6267-71. DOI: 10.1002/anie.201402634. View

Aquino-Jarquin G . Novel Engineered Programmable Systems for ADAR-Mediated RNA Editing. Mol Ther Nucleic Acids. 2020; 19:1065-1072. PMC: 7015837. DOI: 10.1016/j.omtn.2019.12.042. View

George C, Wagner M, Samuel C . Expression of interferon-inducible RNA adenosine deaminase ADAR1 during pathogen infection and mouse embryo development involves tissue-selective promoter utilization and alternative splicing. J Biol Chem. 2005; 280(15):15020-8. DOI: 10.1074/jbc.M500476200. View

Crudele J, Chamberlain J . Cas9 immunity creates challenges for CRISPR gene editing therapies. Nat Commun. 2018; 9(1):3497. PMC: 6115392. DOI: 10.1038/s41467-018-05843-9. View

Matthews M, Thomas J, Zheng Y, Tran K, Phelps K, Scott A . Structures of human ADAR2 bound to dsRNA reveal base-flipping mechanism and basis for site selectivity. Nat Struct Mol Biol. 2016; 23(5):426-33. PMC: 4918759. DOI: 10.1038/nsmb.3203. View

Stafforst T, Schneider M . An RNA-deaminase conjugate selectively repairs point mutations. Angew Chem Int Ed Engl. 2012; 51(44):11166-9. DOI: 10.1002/anie.201206489. View

10.

Abudayyeh O, Gootenberg J, Konermann S, Joung J, Slaymaker I, Cox D . C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector. Science. 2016; 353(6299):aaf5573. PMC: 5127784. DOI: 10.1126/science.aaf5573. View

11.

Anant S, MacGinnitie A, Davidson N . apobec-1, the catalytic subunit of the mammalian apolipoprotein B mRNA editing enzyme, is a novel RNA-binding protein. J Biol Chem. 1995; 270(24):14762-7. View

12.

Stroppel A, Latifi N, Hanswillemenke A, Tasakis R, Papavasiliou F, Stafforst T . Harnessing self-labeling enzymes for selective and concurrent A-to-I and C-to-U RNA base editing. Nucleic Acids Res. 2021; 49(16):e95. PMC: 8450088. DOI: 10.1093/nar/gkab541. View

13.

Los G, Encell L, McDougall M, Hartzell D, Karassina N, Zimprich C . HaloTag: a novel protein labeling technology for cell imaging and protein analysis. ACS Chem Biol. 2008; 3(6):373-82. DOI: 10.1021/cb800025k. View

14.

Krutzfeldt J, Rajewsky N, Braich R, Rajeev K, Tuschl T, Manoharan M . Silencing of microRNAs in vivo with 'antagomirs'. Nature. 2005; 438(7068):685-9. DOI: 10.1038/nature04303. View

15.

Shmakov S, Smargon A, Scott D, Cox D, Pyzocha N, Yan W . Diversity and evolution of class 2 CRISPR-Cas systems. Nat Rev Microbiol. 2017; 15(3):169-182. PMC: 5851899. DOI: 10.1038/nrmicro.2016.184. View

16.

Chen G, Katrekar D, Mali P . RNA-Guided Adenosine Deaminases: Advances and Challenges for Therapeutic RNA Editing. Biochemistry. 2019; 58(15):1947-1957. DOI: 10.1021/acs.biochem.9b00046. View

17.

Sinnamon J, Kim S, Fisk J, Song Z, Nakai H, Jeng S . In Vivo Repair of a Protein Underlying a Neurological Disorder by Programmable RNA Editing. Cell Rep. 2020; 32(2):107878. PMC: 7449137. DOI: 10.1016/j.celrep.2020.107878. View

18.

Wettengel J, Reautschnig P, Geisler S, Kahle P, Stafforst T . Harnessing human ADAR2 for RNA repair - Recoding a PINK1 mutation rescues mitophagy. Nucleic Acids Res. 2016; 45(5):2797-2808. PMC: 5389476. DOI: 10.1093/nar/gkw911. View

19.

Kosicki M, Tomberg K, Bradley A . Repair of double-strand breaks induced by CRISPR-Cas9 leads to large deletions and complex rearrangements. Nat Biotechnol. 2018; 36(8):765-771. PMC: 6390938. DOI: 10.1038/nbt.4192. View

20.

Azad M, Bhakta S, Tsukahara T . Site-directed RNA editing by adenosine deaminase acting on RNA for correction of the genetic code in gene therapy. Gene Ther. 2017; 24(12):779-786. DOI: 10.1038/gt.2017.90. View